Idiosyncratic drug-induced liver injury (DILI) is among the most common causes of acute liver failure in the United States, accounting for approximately 13% of cases. A prospective study was begun in 2003 to recruit patients with suspected DILI and create a repository of biological samples for analysis. This report summarizes the causes, clinical features, and outcomes from the first 300 patients enrolled
The long-term outcomes of patients with drug induced liver injury (DILI) are not well described. The...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/109945/1/cptclpt2010100.pd
Drug-induced liver injury (DILI) remains a significant clinical challenge and is the leading cause o...
Idiosyncratic drug-induced liver injury (DILI) is among the most common causes of acute liver failur...
The drug-induced liver injury network (DILIN) is conducting a prospective study of patients with DIL...
The drug-induced liver injury network (DILIN) is conducting a prospective study of patients with DIL...
Background and Aims Idiosyncratic drug-induced liver injury (DILI) is among the most common causes o...
Drug-induced liver injury (DILI) is an uncommon adverse drug reaction of increasing importance to th...
Drug-induced liver injury (DILI) is an uncommon adverse drug reaction of increasing importance to th...
Little is known about the incidence of drug-induced liver injury (DILI) and risk factors for adverse...
Little is known about the incidence of drug-induced liver injury (DILI) and risk factors for adverse...
BACKGROUND & AIMS: The Drug-Induced Liver Injury Network is conducting a prospective study of patien...
Drug-induced liver injury (DILI) is an important cause of death and indication for liver transplanta...
Drug‐induced liver injury (DILI) is an uncommon but important cause of liver disease that can arise ...
The long-term outcomes of patients with drug induced liver injury (DILI) are not well described. The...
The long-term outcomes of patients with drug induced liver injury (DILI) are not well described. The...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/109945/1/cptclpt2010100.pd
Drug-induced liver injury (DILI) remains a significant clinical challenge and is the leading cause o...
Idiosyncratic drug-induced liver injury (DILI) is among the most common causes of acute liver failur...
The drug-induced liver injury network (DILIN) is conducting a prospective study of patients with DIL...
The drug-induced liver injury network (DILIN) is conducting a prospective study of patients with DIL...
Background and Aims Idiosyncratic drug-induced liver injury (DILI) is among the most common causes o...
Drug-induced liver injury (DILI) is an uncommon adverse drug reaction of increasing importance to th...
Drug-induced liver injury (DILI) is an uncommon adverse drug reaction of increasing importance to th...
Little is known about the incidence of drug-induced liver injury (DILI) and risk factors for adverse...
Little is known about the incidence of drug-induced liver injury (DILI) and risk factors for adverse...
BACKGROUND & AIMS: The Drug-Induced Liver Injury Network is conducting a prospective study of patien...
Drug-induced liver injury (DILI) is an important cause of death and indication for liver transplanta...
Drug‐induced liver injury (DILI) is an uncommon but important cause of liver disease that can arise ...
The long-term outcomes of patients with drug induced liver injury (DILI) are not well described. The...
The long-term outcomes of patients with drug induced liver injury (DILI) are not well described. The...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/109945/1/cptclpt2010100.pd
Drug-induced liver injury (DILI) remains a significant clinical challenge and is the leading cause o...